Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E B Wheeldon

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Thrombosis and Haemostasis|October 31, 1988
The effect of human recombinant tissue-type plasminogen activator on clinical and laboratory parameters of hemostasis and systemic plasminogen activation in the dog and the ratJ C Bloom, T S Sellers, G C Gries, et al.
Circulatory Shock|June 1, 1991
Therapeutic intervention in a rat model of adult respiratory distress syndrome: II. Lipoxygenase pathway inhibitionC R Turner, M N Lackey, M F Quinlan, et al.
Human Gene Therapy|May 20, 1997
Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory responseJ G Smith, S E Raper, E B Wheeldon, et al.
Human Gene Therapy|August 1, 1996
Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trialS L Eck, J B Alavi, A Alavi, et al.
Human Gene Therapy|December 1, 1996
Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primatesJ C Kucharczuk, S Raper, A A Elshami, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Thrombosis and Haemostasis|October 31, 1988
The effect of human recombinant tissue-type plasminogen activator on clinical and laboratory parameters of hemostasis and systemic plasminogen activation in the dog and the ratJ C Bloom, T S Sellers, G C Gries, et al.
Circulatory Shock|June 1, 1991
Therapeutic intervention in a rat model of adult respiratory distress syndrome: II. Lipoxygenase pathway inhibitionC R Turner, M N Lackey, M F Quinlan, et al.
Human Gene Therapy|May 20, 1997
Intracranial administration of adenovirus expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory responseJ G Smith, S E Raper, E B Wheeldon, et al.
Human Gene Therapy|August 1, 1996
Treatment of advanced CNS malignancies with the recombinant adenovirus H5.010RSVTK: a phase I trialS L Eck, J B Alavi, A Alavi, et al.
Human Gene Therapy|December 1, 1996
Safety of intrapleurally administered recombinant adenovirus carrying herpes simplex thymidine kinase DNA followed by ganciclovir therapy in nonhuman primatesJ C Kucharczuk, S Raper, A A Elshami, et al.
Pageof 5